TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 13,983 call options on the stock. This is an increase of approximately 88% compared to the average volume of 7,433 call options. Insider Activity In related news, Director Laurence N. Charney sold 22,000 […]